Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer

Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer

Lung cancer is one of the most common malignant tumours worldwide, with the highest mortality rate. Approximately 1.6 million deaths owing to lung cancer are reported annually; of which, 85% of deaths occur owing to non-small-cell lung cancer (NSCLC). At present, the conventional treatment methods f...

Full description

Bibliographic Details
Main Authors: Yu-Chen Yang, Can-Jun Zhao, Zhao-Feng Jin, Jin Zheng, Li-Tian Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
NSCLC
USPs
PROTACs
E3 ligase
signalling pathway
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1120828/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1120828/full

Similar Items